Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples